Hamps Bio Limited has successfully completed its strategic acquisition of HSDL Innovative Private Limited, marking a significant milestone in the company's expansion plans. The transaction, valued at INR 2.04 crore, was finalized on March 25, 2026, transforming HSDL Innovative Private Limited into a wholly owned subsidiary.

Acquisition Details

The acquisition involved the purchase of 100% paid-up equity share capital of HSDL Innovative Private Limited through a cash transaction. The company acquired the shares from existing shareholders of the target company for a total purchase consideration of INR 2,04,00,000 (Rupees Two Crore Four Lakhs only).

Regulatory Compliance

Hamps Bio Limited informed the BSE about the completion of this acquisition under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. This announcement serves as a continuation of the company's earlier communication dated February 14, 2026, when the acquisition plan was first disclosed to the stock exchanges.

The company has confirmed that all information required under Regulation 30 read with Schedule III of the SEBI Listing Regulations, along with SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, was previously provided to the stock exchanges through their letter dated February 14, 2026.

Corporate Structure Impact

With the completion of this acquisition, HSDL Innovative Private Limited has become a wholly owned subsidiary of Hamps Bio Limited effective March 25, 2026. This strategic move strengthens Hamps Bio Limited's corporate structure and potentially expands its operational capabilities through the integration of HSDL Innovative Private Limited's business activities.

The acquisition documentation was signed by Komal Jain, Company Secretary & Compliance Officer of Hamps Bio Limited, who holds membership number ACS A40470. The company has made this information available on its official website at www.hampsbio.com for stakeholder reference.

Hamps Bio Limited has announced its decision to acquire 100% equity stake in HSDL Innovative Private Limited for ₹2,03,78,718.21 through a cash transaction. The acquisition has been disclosed under SEBI LODR regulations as it constitutes a related party transaction, with the company's promoters and their relatives being existing shareholders of the target entity.

Target Company Profile

HSDL Innovative Private Limited, incorporated on February 17, 2017, operates in the freeze-drying food process business. The company is headquartered at Shop No 410, 4th Floor, Royal Platinum, Palanpore, Surat, Gujarat, and specializes in freeze-drying fruits, vegetables, herbs and ready-to-eat foods.

Financial Performance

The target company has demonstrated consistent growth in its turnover over the past three financial years. HSDL Innovative reported a turnover of ₹1,86,64,115.42 for the financial year ended March 31, 2025, according to its last audited financial statements.

Transaction Details

The acquisition involves a cash consideration of ₹2,03,78,718.21 for acquiring 100% equity shares of HSDL Innovative Private Limited. Post-acquisition, Hamps Bio Limited will hold complete control over the target company, making it a wholly-owned subsidiary.

Strategic Rationale

The management of Hamps Bio Limited has proposed this acquisition with the objective to consolidate the business of freeze-drying food process and freeze-drying fruits, vegetables, herbs and ready-to-eat foods under the umbrella of Hamps Bio Limited. This strategic move aims to create a wholly-owned subsidiary structure for better operational control and business integration.

Regulatory Compliance

The transaction has been classified as a related party transaction under the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The promoters of Hamps Bio Limited along with their relatives are existing shareholders of HSDL Innovative Private Limited, necessitating this disclosure under regulatory requirements. No governmental or regulatory approvals are required for completing this acquisition.